Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.H1 Revenue Doubles For Biota
Total revenue was $61.7m, up 84% from $33.5m on the comparable period last year. Revenue included $56.7m of Relenza royalties $1.4m of collaboration income from licensing agreements with
Total revenue was $61.7m, up 84% from $33.5m on the comparable period last year. Revenue included $56.7m of Relenza royalties $1.4m of collaboration income from licensing agreements with
Collaboration between the two organizations will ensure the sanitary and epidemiological well being of the country’s inhabitants during scientific research, development work, production, consumption, and disposal of products,
The Syro Wave peptide synthesis system offers both microwave and parallel peptide synthesis capabilities. Biotage said that to date peptide synthesis labs have been required to invest in
Frank Rizzo, CEO of XenaCare, said: “As one of the largest food retailers in the United States, Winn-Dixie provides Cobroxin with significant retail coverage throughout the Southeastern United
The ESA APPRISE Oncology program will be launched on March 24, 2010. Direct patient registration or approval prior to ESA administration is not required through the ESA APPRISE
The new study was published in the current edition of Clinical Cancer Research, a journal of the American Association for cancer research. Seliciclib is currently in Phase 2
The issued Hong Kong patent, HK 1071054, entitled ‘Stabilized Reverse Micelle Compositions and Uses Thereof’ covers lipid structures that promote the intestinal absorption of peptides and other sensitive
OTO-104 is a proprietary formulation of the steroid dexamethasone designed to provide sustained drug release to the inner ear from a single IT injection. Preclinical studies confirm the
Oscar Podesta, executive director of Chiltern in Latin America, said: “Our office, strategically located in suburban Pilar, is a natural next step to our development in Argentina. The
Mederma stretch marks therapy is a patented formula that combines a blend of ingredients, including the proprietary botanical extract Cepalin, hyaluronic acid and centella asiatica leaf extract. Merz